Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer.
Dreijerink KM, Groner AC, Vos ES, Font-Tello A, Gu L, Chi D, Reyes J, Cook J, Lim E, Lin CY, de Laat W, Rao PK, Long HW, Brown M. Cell Rep. 2017 Mar 7;18(10):2359-2372. doi: 10.1016/j.celrep.2017.02.025. PMID: 28273452 Free Article https://www.ncbi.nlm.nih.gov/pubmed/28273452
Management of MEN1 Related Nonfunctioning Pancreatic NETs: A Shifting Paradigm: Results From the DutchMEN1 Study Group.
Nell S, Verkooijen HM, Pieterman CR, de Herder WW, Hermus AR, Dekkers OM, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Borel Rinkes IH, Vriens MR, Valk GD. Ann Surg. 2017 Mar 2. doi: 10.1097/SLA.0000000000002183. PMID: 28257328 https://www.ncbi.nlm.nih.gov/pubmed/28257328
PROGNOSTIC FACTORS FOR SURVIVAL OF MEN1 PATIENTS WITH DUODENOPANCREATIC TUMORS METASTATIC TO THE LIVER: RESULTS FROM THE DMSG STUDY GROUP.
Conemans EB, Nell S, Pieterman CR, de Herder WW, Dekkers OM, Hermus AR, van der Horst-Schrivers AN, Bisschop PH, Havekes B, Drent ML, Vriens MR, Valk GD. Endocr Pract. 2017 Feb 22. doi: 10.4158/EP161639.OR. PMID: 28225311 https://www.ncbi.nlm.nih.gov/pubmed/28225311
Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database.
Giusti F, Cianferotti L, Boaretto F, Cetani F, Cioppi F, Colao A, Davì MV, Faggiano A, Fanciulli G, Ferolla P, Ferone D, Fossi C, Giudici F, Gronchi G, Loli P, Mantero F, Marcocci C, Marini F, Masi L, Opocher G, Beck-Peccoz P, Persani L, Scillitani A, Sciortino G, Spada A, Tomassetti P, Tonelli F, Brandi […]
Multiple endocrine neoplasia type 1 (MEN1): An update of 208 new germline variants reported in the last nine years.
Concolino P, Costella A, Capoluongo E. Cancer Genet. 2016 Jan-Feb;209(1-2):36-41. doi: 10.1016/j.cancergen.2015.12.002. Review. PMID: 26767918 https://www.ncbi.nlm.nih.gov/pubmed/26767918
Ventricular fibrillation resulting from electrolyte imbalance reveals vipoma in MEN1 syndrome.
Cavalli T, Giudici F, Santi R, Nesi G, Brandi ML, Tonelli F. Fam Cancer. 2016 Oct;15(4):645-9. https://www.ncbi.nlm.nih.gov/pubmed/27071757
Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study Group.
van Leeuwaarde RS, van Nesselrooij BP, Hermus AR, Dekkers OM, de Herder WW, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Vriens MR, de Laat JM, Pieterman CR, Valk GD. J Clin Endocrinol Metab. 2016 Mar;101(3):1159-65. doi: 10.1210/jc.2015-3766 PMID: 26751192 https://www.ncbi.nlm.nih.gov/pubmed/26751192
Surgery in MEN 2A Patients Older Than 5 Years with Micro-MTC: Outcome at Long-term Follow-up.
Tonelli F, Giudici F, Marcucci T, Cavalli T, Spini S, Gheri RG, Brandi ML. Otolaryngol Head Neck Surg. 155(5):787-789, 2016. https://www.ncbi.nlm.nih.gov/pubmed/27406704
Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1).
Giusti F, Cianferotti L, Gronchi G, Cioppi F, Masi L, Faggiano A, Colao A, Ferolla P, Brandi ML. Endocrine. 2016 Jun;52(3):495-506. Epub 2015 Jul 30. https://www.ncbi.nlm.nih.gov/pubmed/26224587
An autoregulatory network between menin and pri-miR-24-1 is required for the processing of its specific modulator miR-24-1 in BON1 cells.
Luzi E, Marini F, Ciuffi S, Galli G, Brandi ML. Mol Biosyst. 2016 May 24;12(6):1922-8. https://www.ncbi.nlm.nih.gov/pubmed/27098433
